New stock news | Shanghai Longqi plans to go public in Hong Kong. The China Securities Regulatory Commission requires an explanation of the actual operation of medical device business, etc.

According to the Wisdom Financial APP, on September 5th, the China Securities Regulatory Commission announced the requirements for supplementary materials for overseas issuance and listing filing (August 29, 2025 - September 4, 2025) to be made public. The CSRC requested Shanghai Longqi to provide further clarification on the actual operations of the first, second, and third categories of medical device production, first and second category of medical device sales, and third category of medical device business included in the company and its subsidiaries' business scope, whether they have obtained the corresponding qualifications, and whether they are involved in the field of the "Special Management Measures for Foreign Investment Access (Negative List) (2024 Version)". At the same time, it should be explained whether the business scope of the company's subsidiaries is related to the "Special Management Measures for Foreign Investment Access (Negative List) (2024 Version)". On June 27th, Shanghai Longqi submitted documents to the Hong Kong Stock Exchange, with Citigroup, Haitong International, and Guotai Junan International acting as joint sponsors.